CD52 and cerebral cavernous malformation: We demonstrate here that the miR-27a/VE-cadherin interaction is CCM relevant and can be targeted by CD5-2 to normalize the vasculature of CCM lesions, resulting in decreased inflammation and inhibition of CCM pathologies.